Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

被引:12
|
作者
Bashashati, Mohammad [1 ]
Hejazi, Reza A. [2 ]
Andrews, Christopher N. [3 ]
Storr, Martin A. [1 ,4 ]
机构
[1] Univ Calgary, Gastrointestinal Res Grp, Calgary, AB, Canada
[2] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Internal Med, El Paso, TX USA
[3] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB, Canada
[4] Univ Munich, Div Gastroenterol, Munich, Germany
来源
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2014年 / 28卷 / 06期
关键词
Gastroesophageal reflux disease; Heartburn; Proton pump inhibitor; NONCARDIAC CHEST-PAIN; MULTICHANNEL INTRALUMINAL IMPEDANCE; DILATED INTERCELLULAR SPACES; IRRITABLE-BOWEL-SYNDROME; EOSINOPHILIC ESOPHAGITIS; SPHINCTER RELAXATIONS; FUNCTIONAL HEARTBURN; VISCERAL HYPERSENSITIVITY; EROSIVE ESOPHAGITIS; HEALTHY-VOLUNTEERS;
D O I
10.1155/2014/904707
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastroesophageal reflux (GER) is a common gastrointestinal process that can generate symptoms of heartburn and chest pain. Proton pump inhibitors (PPIs) are the gold standard for the treatment of GER; however, a substantial group of GER patients fail to respond to PPIs. In the past, it was believed that acid reflux into the esophagus causes all, or at least the majority, of symptoms attributed to GER, with both erosive esophagitis and nonerosive outcomes. However, with modern testing techniques it has been shown that, in addition to acid reflux, the reflux of nonacid gastric and duodenal contents into the esophagus may also induce GER symptoms. It remains unknown how weakly acidic or alkaline refluxate with a pH similar to a normal diet induces GER symptoms. Esophageal hypersensitivity or functional dyspepsia with superimposed heartburn may be other mechanisms of symptom generation, often completely unrelated to GER. Detailed studies investigating the pathophysiology of esophageal hypersensitivity are not conclusive, and definitions of the various disease states may overlap and are often confusing. The authors aim to clarify the pathophysiology, definition, diagnostic techniques and medical treatment of patients with heartburn symptoms who fail PPI therapy.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [41] Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
    Mermelstein, Joseph
    Mermelstein, Alanna Chait
    Chait, Maxwell M.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2018, 11 : 119 - 134
  • [42] A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease
    Hillman, L.
    Yadlapati, R.
    Thuluvath, A. J.
    Berendsen, M. A.
    Pandolfino, J. E.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (09): : 1 - 15
  • [43] Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease
    Cheong, Jae Hoon
    Kim, Gwang Ha
    Lee, Bong Eun
    Choi, Moon Ki
    Moon, Ji Yoon
    Ryu, Dong Yup
    Kim, Dong Uk
    Song, Geun Am
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (7-8) : 789 - 796
  • [44] Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
    Reidar Fossmark
    Eivind Ness-Jensen
    Øystein Sørdal
    BMC Gastroenterology, 23
  • [45] Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease
    Michele Cicala
    Sara Emerenziani
    Michele Pier Luca Guarino
    Mentore Ribolsi
    World Journal of Gastroenterology, 2013, (39) : 6529 - 6535
  • [46] Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: Normalization by treatment with a proton pump inhibitor
    Mine, Shinichiro
    Iida, Takeshi
    Tabata, Takahiro
    Okada, Yosuke
    Tanaka, Yoshiya
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (02) : 303 - 309
  • [47] Reflux symptoms and reflux disease. Does it always have to be a proton pump inhibitor?
    Labenz, Joachim
    GASTROENTEROLOGIE, 2024, : 512 - 523
  • [48] Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy
    Galindo, G.
    Vassalle, J.
    Marcus, S. N.
    Triadafilopoulos, G.
    DISEASES OF THE ESOPHAGUS, 2013, 26 (05) : 443 - 450
  • [49] A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease
    Ota, Kazuhiro
    Takeuchi, Toshihisa
    Harada, Satoshi
    Edogawa, Shoko
    Kojima, Yuichi
    Inoue, Takuya
    Higuchi, Kazuhide
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (12) : 1409 - 1413
  • [50] Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy
    Kawai, Takashi
    Hirayama, Yoji
    Oguchi, Aiko
    Ishii, Fumi
    Matushita, Masanao
    Kitayama, Naoya
    Morishita, Shinji
    Hiratsuka, Noboru
    Ohata, Ken
    Konishi, Hiroyuki
    Kishino, Maiko
    Nakamura, Shinichi
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2017, 60 (02) : 143 - 145